Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. [electronic resource]
Producer: 20040224Description: 467-74 p. digitalISSN:- 0013-7227
- Adenoviridae -- genetics
- Animals
- Gene Expression
- Genetic Therapy
- Genetic Vectors
- Glucocorticoids -- administration & dosage
- Graft Survival
- Hepatocyte Growth Factor -- genetics
- Immunosuppressive Agents -- administration & dosage
- Insulin -- blood
- Insulin Resistance
- Islets of Langerhans -- drug effects
- Islets of Langerhans Transplantation -- methods
- Male
- Mice
- Portal Vein
- Rats
- Rats, Inbred Lew
- Rats, Sprague-Dawley
- Reverse Transcriptase Polymerase Chain Reaction
- Transfection
- Transplantation, Homologous
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.